Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0266-2023Class II

InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC

Allison Medical, Inc. / initiated 2018-01-19 / Completed / root cause: labeling and UDI

Allison Medical, Inc. began a recall of InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC on . FDA classified it as Class II and gives the reason as "Insulin syringe retail packages incorrectly labeled as "Short Needle"". As of , the recall status on record is Completed, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0266-2023
Classification
Class II
Status
Completed
Initiated
Posted
Recalling firm
Allison Medical, Inc.
Product
InControl Insulin Syringes, Short Needle, 29 Gauge, 1CC
Product code
FMF Syringe, Piston
Reason for recall
Insulin syringe retail packages incorrectly labeled as "Short Needle".
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
On 01/19/2018, The recalling firm notified their customer of the recall.
Quantity in commerce
1,500 Boxes (150,000 syringes)
Distribution
Texas
Product codes and lots
UDI/Lot/Expiration: 00041220791484/ 170407/ 2022-03-31

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0266-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0266-2023Class IICompletedVoluntary: Firm initiated